New Assessment System in Measuring Symptom Distress in Cancer Patients
Launched by M.D. ANDERSON CANCER CENTER · Jul 20, 2007
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to measure how symptoms affect the lives of cancer patients. The researchers want to see if a new assessment tool developed by MD Anderson can provide better information on the common symptoms that cancer patients experience and how these symptoms impact their quality of life. By understanding this better, healthcare providers can improve care for patients undergoing treatment.
To participate in the trial, you need to be at least 18 years old and either a cancer patient receiving care at UT MD Anderson, a family caregiver of a patient, or a healthcare professional with experience in treating cancer. If you join the study, you can expect to share your experiences and provide feedback on your symptoms. This research aims to help improve how symptoms are assessed and managed in cancer care, ultimately enhancing the well-being of patients and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • NORMAL SAMPLES: Community dwelling adults 18 years of age or older
- • PATIENT SAMPLES: Inpatients and outpatients 18 years of age or older, being followed at UT MD Anderson
- • EXPERT PANEL PROFESSIONAL PARTICIPANTS: Physician or other healthcare provider with at least 5 years of experience caring for patients with the disease and/or treatment of interest, at least one publication in the last 5 years dealing with the disease and/or treatment of interest (physician only), ability to speak and read English, consent to participate
- • EXPERT PANEL FAMILY CAREGIVERS PARTICIPANTS: Identification as a family caregiver by patient enrolled as expert panel participant with the disease and/or treatment of interest, 18 years of age or older, ability to speak and read English, consent to participate
- • EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on Expert Panel, willingness to receive packet for expert panel participation
- Exclusion Criteria:
- • EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on expert panel, willingness to receive packet for expert panel participation
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Xin Shelley Wang
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials